Funding:
Clinical challenges in the SOCMA study were funded through grant funds awarded by Jon Moulton Charity Trust, UK Medical Research Council (ref MR/S036954/1), Sociedad Española de Alergología e Inmunología Clínica (SEAIC), Sociedad Española de Inmunología Clínica, Alergología y Asma Pediátrica (SEICAP) and Instituto de Salud Carlos III and FEDER funds for the ARADyAL research network (RD16/006/0026). RB is supported by a Río Hortega Research Contract through the Instituto de Salud Carlos III and the European Social Fund (ref CM20/00253). MVO was supported by a Marie Skłodowska-Curie actions - Research Fellowship funded by the Commission of the European Communities (reference: 656878). PJT is supported through the NIHR Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR, or the Department of Health.
The funders of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.